Alessandro Rametta

9PUBLICATIONS
13CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 25, 2026
Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial.

|Sep 02, 2026
Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

|Jun 10, 2026
Local treatment of the primary tumor in mHSPC in the ARPI era: incremental value or overtreatment?

|May 06, 2026
177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

|May 04, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma.

|Jan 10, 2026
An update on the treatment paradigm for non-clear cell renal cell carcinoma.

Alessandro Rametta, Noemi Crippa, Simone Rota

Pageof 2

Frequent Collaborators

4 joint publications

Giuseppe Procopio

4 joint publications

Marco Stellato

1 joint publications

Simone Rota

1 joint publications

Giuseppe Fotia